The U.S. Food and Drug Administration recognized depression as a potential side effect of finasteride in 2011 and recognized suicidality as a potential side effect in 2022.
January 01, 2011
high
temporal
Regulatory labeling acknowledgments by the FDA regarding neuropsychiatric adverse effects of finasteride.
The U.S. Food and Drug Administration recorded 18 suicides linked to finasteride in 2011.
January 01, 2011
high
statistical
A reported count of suicide cases associated with finasteride in FDA records for 2011.